Kondo, K.

Bristol-Myers Squibb (United States)

1 paper on CoChatORCID 0009-0008-7529-4791

Most cited papers

Verified
LBA6_PR Nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): First results of the CheckMate 649 study
Moehler, M., Shitara, K., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., Liu, T., et al. (2020) · Annals of Oncology
Gastric Cancer Management and OutcomesCancer Immunotherapy and Biomarkers
Cited by 208

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free